Evvy’s $40M Bet on Women’s Health | Tech News

Evvy just landed $40M in Series B funding to revolutionize women’s health with its at-home vaginal microbiome test—just a swab, mail it in, get CLIA/CLEP-certified results, personalized care plans, and even prescriptions. Already serving 100K patients and partnering with 3K clinicians, Evvy has published 15 peer-reviewed papers, discovered new BV subtypes, and cataloged hundreds of unseen microbial genomes. Their AI assistant, EvvyAI, helps users decode their data and connect with experts. Now expanding into fertility, they’re linking microbiome insights to IVF outcomes and pregnancy loss, aiming to turn routine testing into a powerful tool for proactive, science-backed women’s health.

Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Sources:
https://techcrunch.com/2026/09/15/evvy-raises-40m-as-it-seeks-to-further-womens-health-research-with-vaginal-microbiome-data/

More coverage & latest updates:
https://sources.thednn.ai/4b177e1f3cbdd2ce

Report issues to feedback@thednn.ai.